According to a quantitative analysis, 28.83% of the tumor tissues expressed PD-L1, only 7.17% of the normal tissue expressed PD-L1, and PD-L1 expression positively related to the PERK levels (Fig. 3D). This evidence concerns the gene CD274 and neoplasm.